GE Of Southeast Asia Seeks To Launch 100 Medical Innovations In Area
This article was originally published in PharmAsia News
Executive Summary
General Electric, a U.S. maker of medical devices and other health care products, is moving to become a major player in the Asia Pacific region, building on its previously announced $6 billion, six-year initiative. GE Healthcare's CEO for Southeast Asia, Arun Sharma, said in an interview his company expects to launch more than 100 innovations in the health care area, with an emphasis on reducing the cost of equipment and increasing access to products that contribute to the quality of health care. Arun said a key part of the plan is digitizing as many medical applications and equipment as possible. (Click here for more
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.